VSTAT120 REDUCES THE INNATE INFLAMMATORY RESPONSE TO INFECTION AND ENHANCES ONCOLYTIC VIRAL THERAPY FOR GLIOBLASTOMA

BACKGROUND: A major barrier to oncolytic virus (OV) efficacy for the treatment of Glioblastoma is the innate immune response; this response limits virus replication and reduces tumor cell destruction. Our lab developed a novel OV, RAMBO, which expresses the anti-angiogenic fragment Vasculostatin (Vs...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kaur, Balveen, Meisen, W. Hans, Hardcastle, Jayson, Wojton, Jeffrey, Wohleb, Eric, Alvarez-Breckenridge, Christopher, Pow-anpongkul, Pete, Godbout, Jonathan
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2014
Matèries:
abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4144633/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou209.2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars